RAC1 and lung carcinoma: For example, PIKfyve promotes cell migration and invasion through activation of Rac1 in lung carcinoma, osteosarcoma or rhabdomyosarcoma cells, while inhibition of PIKfyve resulted in a significant decrease in cell migration velocity and persistence [52].